{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:34:24Z","timestamp":1793421264749,"version":"4.5.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    \u03b3\u03b4 T cells represent a promising cell platform for adoptive cell therapy. Their natural anti-tumor reactivity and HLA-independent target cell recognition make them an attractive platform for allogeneic adoptive immunotherapy clinical interventions. Initial clinical trials exploring allogeneic \u03b3\u03b4 T-cell therapies have demonstrated encouraging safety profiles. However, their therapeutic efficacy, especially against solid tumors, remains limited. This highlights the need for further optimization of \u03b3\u03b4 T cell products to improve anti-tumor potency, such as the increased targeting induced by the expression of a chimeric antigen receptors (CAR). However, a critical challenge in the development of CAR-\u03b3\u03b4 T cell therapies has been optimizing transduction efficiency with standard vector formats allowing for optimal CAR transgene expression that then produces an optimal therapeutic product. Here we present an effective method for enhancing CAR transgene expression in \u03b3\u03b4 T cells using a Baboon-pseudotyped lentiviral vector (BaEV-LV), comparing it to the conventional vesicular-stomatitis-virus-G protein (VSV-G) LVs. BaEV-LV significantly enhanced the transduction efficiency of \u03b3\u03b4 T cells with CARs, while conserving the beneficial cell product composition and phenotype of untransduced \u03b3\u03b4 T cells. The \u03b3\u03b4 T cells transduced with BaEV-LV CARs demonstrated significantly enhanced cytotoxicity against B7H3-expressing tumor cells in both 2D and 3D\n                    <jats:italic>in vitro<\/jats:italic>\n                    models. Our findings represent a significant advancement in CAR-\u03b3\u03b4 T cell engineering, offering a promising new avenue for cancer immunotherapy that combines the unique properties of V\u03b39V\u03b42 T cells with the targeted specificity of CAR technology. This method is compatible with automated closed-system platforms such as the CliniMACS Prodigy\n                    <jats:sup>\u00ae<\/jats:sup>\n                    , facilitating Good Manufacturing Practice (GMP)-compliant production for clinical trials. This feature significantly enhances the translational potential of engineered \u03b3\u03b4 T cells, paving the way for the development of next-generation \u03b3\u03b4 T cell-based immunotherapies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1548630","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T01:22:50Z","timestamp":1749172970000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Transduction of \u03b3\u03b4 T cells with Baboon envelope pseudotyped lentiviral vector encoding chimeric antigen receptors for translational and clinical applications"],"prefix":"10.3389","volume":"16","author":[{"given":"Lorraine","family":"Pinot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Sa\u00dfor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"M\u00f6ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Verhoeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Villacorta","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimas J.","family":"Orentas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/cells9051206","article-title":"The role of human \u03b3\u03b4 T cells in anti-tumor immunity and their potential for cancer immunotherapy","volume":"9","author":"Liu","year":"2020","journal-title":"Cells"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0515-7","article-title":"Allogeneic V\u03b39V\u03b42 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer","volume":"18","author":"Xu","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.148.8.2315","article-title":"MHC-unrestricted cytotoxic and proliferative responses of two distinct human gamma\/delta T cell subsets to Daudi cells","volume":"148","author":"Fisch","year":"1992","journal-title":"J Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830190907","article-title":"Non-random expression of T cell receptor \u03b3 and \u03b4 variable gene segments in functional T lymphocyte clones from human peripheral blood","volume":"19","author":"Borst","year":"1989","journal-title":"Eur J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/375155a0","article-title":"Natural and synthetic non-peptide antigens recognized by human \u03b3\u03b4 T cells","volume":"375","author":"Tanaka","year":"1995","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021500","article-title":"Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells","volume":"197","author":"Gober","year":"2003","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxm031","article-title":"Preferential recognition of a microbial metabolite by human Vgamma2Vdelta2 T cells","volume":"19","author":"Puan","year":"2007","journal-title":"Int Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"12","author":"Gentles","year":"2015","journal-title":"Nat Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1284723","article-title":"Assessment of tumor-infiltrating TCRV\u03b39V\u03b42 \u03b3\u03b4 lymphocyte abundance by deconvolution of human cancers","volume":"6","author":"Tosolini","year":"2017","journal-title":"Oncoimmunology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0515-7","article-title":"Allogeneic V\u03b39V\u03b42 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer","volume":"18","author":"Xu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1182\/blood-2023-181184","article-title":"Inb-100: A pilot study of donor derived, ex-vivo expanded\/activated gamma-delta T cell (EAGD) infusion following haploidentical hematopoietic stem cell transplantation and post-transplant cyclophosphamide (PTCy)","volume":"142","author":"McGuirk","year":"2023","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.6026\/97320630017460","article-title":"Optimization of methods for peripheral blood mononuclear cells isolation and expansion of human gamma delta T cells","volume":"17","author":"Khan","year":"2021","journal-title":"Bioinformation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.2.384.013k07_384_392","article-title":"Stimulation of \u03b3\u03b4 T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1140623","article-title":"A close look at current \u03b3\u03b4 T-cell immunotherapy","volume":"14","author":"Ma","year":"2023","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2013.03.003","article-title":"Structure and T cell inhibition properties of B7 family member, B7-H3","volume":"21","author":"Vigdorovich","year":"1993","journal-title":"Struct Lond Engl"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3361","article-title":"Breast cancer detection by B7-H3\u2013targeted ultrasound molecular imaging","volume":"75","author":"Bachawal","year":"2015","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1159\/000505756","article-title":"B7-H3 and B7-H4 expression in breast cancer and their association with clinicopathological variables and T cell infiltration","volume":"87","author":"Kim","year":"2020","journal-title":"Pathobiology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/cas.2018.109.issue-9","article-title":"Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma","volume":"109","author":"Wang","year":"2018","journal-title":"Cancer Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-021-01167-w","article-title":"The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional role","volume":"9","author":"Digregorio","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12885-023-10575-1","article-title":"Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types","volume":"23","author":"Dai","year":"2023","journal-title":"BMC Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13045-022-01364-7","article-title":"Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy","volume":"15","author":"Zhao","year":"2022","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1137","article-title":"Bioactivity and safety of B7-H3-targeted chimeric antigen receptor T cells against anaplastic meningioma","volume":"9","author":"Tang","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41392-021-00505-7","article-title":"Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.10011","article-title":"STRIVE-02: A first-in-human phase 1 trial of systemic B7H3 CAR T cells for children and young adults with relapsed\/refractory solid tumors","volume":"40","author":"Pinto","year":"2022","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41591-024-03478-6","article-title":"Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies","volume":"31","author":"Jadlowsky","year":"2025","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-540641","article-title":"Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor","volume":"123","author":"Amirache","year":"2014","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.9831","article-title":"Optimized protocols for \u03b3\u03b4 T cell expansion and lentiviral transduction","volume":"19","author":"Wang","year":"2019","journal-title":"Mol Med Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2021.03.015","article-title":"Efficient lentiviral transduction method to gene modify cord blood CD8+ T cells for cancer therapy applications","volume":"21","author":"Lo Presti","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12860-021-00397-z","article-title":"Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells","volume":"22","author":"Rajabzadeh","year":"2021","journal-title":"BMC Mol Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"12365","DOI":"10.1038\/s41598-023-39597-2","article-title":"Optimized conditions for gene transduction into primary immune cells using viral vectors","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.12.001","article-title":"Chimeric antigen receptor-engineered human gamma delta T cells: enhanced cytotoxicity with retention of cross presentation","volume":"26","author":"Capsomidis","year":"2018","journal-title":"Mol Ther"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003441","article-title":"Off-the-shelf V\u03b41 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma","volume":"9","author":"Makkouk","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.v11.2","article-title":"Allogeneic CD20-targeted \u03b3\u03b4 T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models","volume":"11","author":"Nishimoto","year":"2022","journal-title":"Clin Transl Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-558163","article-title":"Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs","volume":"124","author":"Girard-Gagnepain","year":"2014","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1182\/blood-2010-03-276014","article-title":"Lentiviral vectors and transduction of human cancer B cells","volume":"116","author":"L\u00e9vy","year":"2010","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018027508","article-title":"Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency","volume":"3","author":"Bernadin","year":"2019","journal-title":"Blood Adv"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02873","article-title":"Efficient and robust NK-cell transduction with baboon envelope pseudotyped lentivector","volume":"10","author":"Colamartino","year":"2019","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02001","article-title":"A distinct subset of highly proliferative and lentiviral vector (LV)-transducible NK cells define a readily engineered subset for adoptive cellular therapy","volume":"10","author":"Bari","year":"2019","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/JVI.74.17.8085-8093.2000","article-title":"Sodium-dependent neutral amino acid transporter type 1 is an auxiliary receptor for baboon endogenous retrovirus","volume":"74","author":"Marin","year":"2000","journal-title":"J Virol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.5.2936-2945.2003","article-title":"N-linked glycosylation and sequence changes in a critical negative control region of the ASCT1 and ASCT2 neutral amino acid transporters determine their retroviral receptor functions","volume":"77","author":"Marin","year":"2003","journal-title":"J Virol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-022-00660-2","article-title":"Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia","volume":"12","author":"Albinger","year":"2022","journal-title":"Blood Cancer J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40425-017-0246-1","article-title":"A tandem CD19\/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines","volume":"5","author":"Schneider","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-558163","article-title":"Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs","volume":"124","author":"Girard-Gagnepain","year":"2014","journal-title":"Blood"},{"key":"B46","unstructured":"Lentiviral vectors pseudotyped with mutant BaEV glycoproteins\n          \n          \n            \n              Girard-Gagnepain\n              A\n            \n            \n              Verhoeyen\n              E\n            \n            \n              Lavillette\n              D\n            \n            \n              Cosset\n              FL\n            \n          \n          \n          2016"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13520","article-title":"Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD\/SCID\u03b3c-\/- mice","volume":"14","author":"Levy","year":"2016","journal-title":"J Thromb Haemost"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1089\/hum.2019.157","article-title":"Vectofusin-1 improves transduction of primary human cells with diverse retroviral and lentiviral pseudotypes, enabling robust, automated closed-system manufacturing","volume":"30","author":"Radek","year":"2019","journal-title":"Hum Gene Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.17","article-title":"Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells","volume":"2","author":"Fenard","year":"2013","journal-title":"Mol Ther - Nucleic Acids"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-328526","article-title":"DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by \u03b3\u03b4 T lymphocytes","volume":"118","author":"Nussbaumer","year":"2011","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-234211","article-title":"Human \u03b3\u03b4 T lymphocytes induce robust NK cell\u2013mediated antitumor cytotoxicity through CD137 engagement","volume":"116","author":"Maniar","year":"2010","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.12.6977","article-title":"Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells","volume":"161","author":"Chapoval","year":"1998","journal-title":"J Immunol Baltim Md 1950"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1454427","article-title":"Efficacy and safety of natural killer cell therapy in patients with solid tumors: a systematic review and meta-analysis","volume":"15","author":"Park","year":"2024","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002274","article-title":"Dichotomous and stable gamma delta T-cell number and function in healthy individuals","volume":"9","author":"Ou","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","article-title":"c-Jun overexpression in CAR T cells induces exhaustion resistance","volume":"576","author":"Lynn","year":"2019","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00618","article-title":"\u03b3\u03b4 T cell-mediated antibody-dependent cellular cytotoxicity with CD19 antibodies assessed by an impedance-based label-free real-time cytotoxicity assay","volume":"5","author":"Seidel","year":"2014","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/CJI.0000000000000289","article-title":"Improving immunotherapy against B-cell Malignancies using \u03b3\u03b4 T-cell\u2013specific stimulation and therapeutic monoclonal antibodies","volume":"42","author":"Hoeres","year":"2019","journal-title":"J Immunother"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1126\/science.1110267","article-title":"Professional antigen-presentation function by human gammadelta T Cells","volume":"309","author":"Brandes","year":"2005","journal-title":"Science"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.0810059106","article-title":"Cross-presenting human \u03b3\u03b4 T cells induce robust CD8+ \u03b1\u03b2 T cell responses","volume":"106","author":"Brandes","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.4049\/jimmunol.1700003","article-title":"Antigen-presenting human \u03b3\u03b4 T cells promote intestinal CD4+ T cell expression of IL-22 and mucosal release of calprotectin","volume":"198","author":"Tyler","year":"2017","journal-title":"J Immunol Author Choice"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.522","article-title":"Activated V\u03b39V\u03b42 T cells trigger granulocyte functions via MCP-2 release12","volume":"182","author":"Agrati","year":"2009","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/clim.2002.5218","article-title":"Human gamma delta T cells induce dendritic cell maturation","volume":"103","author":"Ismaili","year":"2002","journal-title":"Clin Immunol Orlando Fla"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00861\/full","article-title":"Potent bidirectional cross-talk between plasmacytoid dendritic cells and \u03b3\u03b4T cells through BTN3A, type I\/II IFNs and immune checkpoints","volume":"11","author":"Girard","year":"2020","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.3.1239","article-title":"\u03b3\/\u03b4 T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes","volume":"181","author":"Horner","year":"1995","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13578-022-00887-3","article-title":"Three-dimensional in vitro culture models in oncology research","volume":"12","author":"Jubelin","year":"2022","journal-title":"Cell Biosci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1548630\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T01:22:51Z","timestamp":1749172971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1548630\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2025.1548630"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1548630","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"article-number":"1548630"}}